Regular ArticlePropafenone Inhibition of Human Atrial Myocyte Repolarizing Currents☆
References (0)
Cited by (26)
Cardiac K<inf>2P</inf>13.1 (THIK-1) two-pore-domain K<sup>+</sup> channels: Pharmacological regulation and remodeling in atrial fibrillation
2019, Progress in Biophysics and Molecular BiologyInhibition of cardiac two-pore-domain K<sup>+</sup> (K<inf>2P</inf>) channels - An emerging antiarrhythmic concept
2014, European Journal of PharmacologyClass i antiarrhythmic drugs inhibit human cardiac two-pore-domain K <sup>+</sup> (K<inf>2P</inf>) channels
2013, European Journal of PharmacologyVentricular rate determines early bradycardic electrical remodeling
2005, Heart RhythmPharmacology of cardiac potassium channels
2004, Cardiovascular ResearchIn silico assessment of class I antiarrhythmic drug effects on pitx2‐induced atrial fibrillation: Insights from populations of electrophysiological models of human atrial cells and tissues
2021, International Journal of Molecular Sciences
- ☆
Please address all correspondence to: Gil J. Gross, Institute of Cardiovascular Sciences, St Boniface General Hospital Research Centre, 351 Taché Avenue, Winnipeg, Manitoba, Canada R2H 2A6.
Copyright © 1998 Academic Press. All rights reserved.